Assessment of geographic access to monoclonal antibodies in the United States

Using spatial modeling techniques, we highlight disparities in access to monoclonal antibodies (mAbs) used to treat COVID-19 patients. Fifteen million individuals in the United States must travel over 30 min to access mAbs. Areas with lower COVID-19 vaccination rates have worse access to essential C...

Descripción completa

Detalles Bibliográficos
Autores principales: Rader, Benjamin, Whaley, Christopher M, Rogers, Wesley S, Brownstein, Professor John S, Cantor, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155997/
https://www.ncbi.nlm.nih.gov/pubmed/35244695
http://dx.doi.org/10.1093/jtm/taac018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155997/
https://www.ncbi.nlm.nih.gov/pubmed/35244695
http://dx.doi.org/10.1093/jtm/taac018

Ejemplares similares